Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

Author: m.nasser

Working with Innovest has been a great experience for Rawabi Farah. Their professional approach, innovative solutions, and commitm...

Rawabi Farah

Partnering with Innovest has been a game-changer for us at Mais Irrigation. Their professional approach, attention to detail, and ...

Partnering with Innovest has been a game-changer for us at Mais Irrigation. Their professional approach, attention to detail, and ...

Aljazeera Hospital